首页> 外国专利> Compositions and combinations of Activator (IS) receptor (PPAR) Activation and Proliferation peroxis0mal inhibitor of Sterol absorption (IS), the use of such combinations or compositions for the manufacture of a Medicament for the treatment for Vascular indications, diabetes Obes

Compositions and combinations of Activator (IS) receptor (PPAR) Activation and Proliferation peroxis0mal inhibitor of Sterol absorption (IS), the use of such combinations or compositions for the manufacture of a Medicament for the treatment for Vascular indications, diabetes Obes

机译:激活剂(IS)受体(PPAR)活化和增殖的组合物和组合物甾醇吸收(IS)的过氧化物抑制剂,此类组合物或组合物在制备用于治疗血管适应症,糖尿病,肥胖症的药物中的用途

摘要

Compositions and therapeutic combinations that include: (a) at least one Activator receptor activation of peroxisomal proliferation; and (b) at least one Sterol Absorption Inhibitor of beta lactam azetidinona replaced or superseded.A composition comprising: (a) a compound represented by the formula (1) or a pharmaceutically acceptable Salt or solvate thereof, (b), (c) lactose Monohydrate, microcrystalline Cellulose, povidone, (d) (e) (f) croscarmellose sodium; Sodium lauryl sulphate, and Magnesium Stearate.Use of these compositions and combinations for the manufacture of a Medicament useful for the treatment of vascular diseases, diabetes, Obesity and reduced plasma levels of Sterols.
机译:组合物和治疗组合,包括:(a)至少一种过氧化物酶体增殖的活化剂受体活化;组合物,其包含:(a)由式(1)表示的化合物或其药学上可接受的盐或溶剂化物,(b),(c);和(b)至少一种β内酰胺氮杂环丁酮的甾醇吸收抑制剂被取代或取代。一水合乳糖,微晶纤维素,聚维酮,(d)(e)(f)交联羧甲基纤维素钠;月桂基硫酸钠和硬脂酸镁。这些组合物和组合物在制备可用于治疗血管疾病,糖尿病,肥胖症和降低甾醇血浆水平的药物中的用途。

著录项

  • 公开/公告号AR033855A1

    专利类型

  • 公开/公告日2004-01-07

    原文格式PDF

  • 申请/专利权人 SCHERING CORPORATION;

    申请/专利号AR2002P100269

  • 发明设计人

    申请日2002-01-25

  • 分类号A61K45/06;A61K31/397;A61K47/00;A61P9/00;A61P3/06;A61P3/10;A61P3/04;A61P3/00;

  • 国家 AR

  • 入库时间 2022-08-21 23:12:28

相似文献

  • 专利
  • 外文文献
  • 中文文献
获取专利

客服邮箱:kefu@zhangqiaokeyan.com

京公网安备:11010802029741号 ICP备案号:京ICP备15016152号-6 六维联合信息科技 (北京) 有限公司©版权所有
  • 客服微信

  • 服务号